Department of Biochemistry, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma Jonan-ku, Fukuoka, Japan.
Chronobiol Int. 2010 Oct;27(9-10):1735-53. doi: 10.3109/07420528.2010.515324.
Acute thrombotic events frequently occur in the early morning among hyperlipidemic patients. The activity of plasminogen activator inhibitor-1 (PAI-1), a potent inhibitor of the fibrinolytic system, oscillates daily, and this is considered one mechanism that underlies the morning onset of acute thrombotic events in hyperlipidemia. Although several studies have reported the expression of the PAI-1 gene is under the control of the circadian clock system, the molecular mechanism of the circadian transactivation of PAI-1 gene under hyperlipidemic conditions remains to be elucidated. Here, the authors investigated whether hyperlipidemia induced by a high-fat diet (HFD) enhances the daily oscillation of plasma PAI-1 activity in mice. The mRNA levels of the PAI-1 gene were increased and rhythmically fluctuated with high-oscillation amplitude in the livers of wild-type mice fed with the HFD. Circadian expression of proxisome proliferator-activated receptor-α (PPARα) mRNA was also augmented as well as that of PAI-1. Chromatin immunoprecipitation showed the HFD-induced hyperlipidemia significantly increased the binding of PPARα to the PAI-1 promoter. Luciferase reporter analysis using primary hepatocytes revealed CLOCK/BMAL1-mediated PAI-1 promoter activity was synergistically enhanced by cotransfection with PPARα/retinoid X receptor-α (RXRα), and this synergistic transactivation was repressed by negative limbs of the circadian clock, PERIOD2 and CRYPTOCHROME1. As expected, HFD-induced PAI-1 mRNA expression was significantly attenuated in PPARα-null mice. These results suggest a molecular link between the circadian clock and lipid metabolism system in the regulation of PAI-1 gene expression, and provide an aid for understanding why hyperlipidemia increases the risk of acute thrombotic events in the morning.
高脂血症患者常于清晨发生急性血栓事件。纤溶系统的强力抑制剂——纤溶酶原激活物抑制剂-1(PAI-1)的活性呈日周期波动,这被认为是高脂血症患者清晨发生急性血栓事件的机制之一。尽管有几项研究报道了 PAI-1 基因的表达受昼夜节律钟系统的控制,但在高脂血症条件下 PAI-1 基因昼夜转录激活的分子机制仍有待阐明。在这里,作者研究了高脂饮食(HFD)是否会增强小鼠血浆 PAI-1 活性的日常波动。HFD 喂养的野生型小鼠肝脏中 PAI-1 基因的 mRNA 水平升高,并呈高振幅的节律性波动。过氧化物酶体增殖物激活受体-α(PPARα)mRNA 的昼夜表达也增强,同时 PAI-1 的表达也增强。染色质免疫沉淀显示,HFD 诱导的高脂血症显著增加了 PPARα 与 PAI-1 启动子的结合。使用原代肝细胞进行的荧光素酶报告基因分析显示,CLOCK/BMAL1 介导的 PAI-1 启动子活性通过与 PPARα/视黄酸受体-α(RXRα)共转染而协同增强,这种协同转录激活受到昼夜钟负性臂 PERIOD2 和 CRYPTOCHROME1 的抑制。正如预期的那样,PPARα 缺失小鼠中 HFD 诱导的 PAI-1 mRNA 表达显著减弱。这些结果表明昼夜钟和脂质代谢系统之间存在分子联系,在调节 PAI-1 基因表达方面发挥作用,并为理解为什么高脂血症会增加清晨发生急性血栓事件的风险提供了帮助。